Tenderwize
Back to tender search

Open-House Supply Agreement for Therapy Allergens for Subcutaneous Immunotherapy

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 564 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Therapie-Allergene zur subkutanen Immuntherapie, ATC V01AA02

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

62 / 100

Complexity

48 / 100

Risk factors

Contract documents must be submitted through the DTVP communications area and not through the offer area; using the wro...

Participation is limited to pharmaceutical companies and requires a signed reliability declaration; missing this would...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Non-exclusive open-house supply arrangement for therapy allergens for subcutaneous immunotherapy (ATC V01AA02).
  • Contract terms are pre-set and not individually negotiable.
Show full summary

This is an open-house supply arrangement by AOK Bayern for pharmaceutical products (therapy allergens for subcutaneous immunotherapy, ATC V01AA02). It is explicitly described as not a standard competitive procurement, with identical non-exclusive contracts offered to all interested pharmaceutical companies meeting the stated suitability requirement. No contract value is provided. Submission is through DTVP or by paper originals in duplicate, with bilingual constraint to German and mandatory German translation for non-German documents. The notice is highly specific on contract start/end timing and monthly cut-off dates.

Risks

Contract documents must be submitted through the DTVP communications area and not through the offer area; using the wro...

Participation is limited to pharmaceutical companies and requires a signed reliability declaration; missing this would...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contractual partners.

Administrative

  • Submit a signed reliability self-declaration.
  • Submit the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-House Supply Agreement for Therapy Allergens for Subcutaneous Immunotherapy

Open-house non-exclusive supply contract for therapy allergens for subcutaneous immunotherapy (ATC V01AA02). Scope is defined in the contract and related annexes downloadable from the tender documents. The notice says only pharmaceutical companies may become contractual partners. Lot information is from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Deadline

Deadline Mar 03, 2028

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
179863-2026

Documents (2)

Similar tenders